Biodesix Inc
NASDAQ:BDSX

Watchlist Manager
Biodesix Inc Logo
Biodesix Inc
NASDAQ:BDSX
Watchlist
Price: 0.4238 USD 3.34% Market Closed
Market Cap: 62.1m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+321%
Revenue
Forecast
+22%
Operating Income
Forecast
+34%
Net Income
Forecast
+31%

Wall Street
Price Targets

BDSX Price Targets Summary
Biodesix Inc

Wall Street analysts forecast BDSX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BDSX is 1.785 USD with a low forecast of 1.515 USD and a high forecast of 2.1 USD.

BDSX Lowest Forecast
Wall Street Target
1.515 USD
257% Upside
BDSX Average Forecast
Wall Street Target
1.785 USD
321% Upside
BDSX Highest Forecast
Wall Street Target
2.1 USD
396% Upside
Lowest
Price Target
1.515 USD
257% Upside
Average
Price Target
1.785 USD
321% Upside
Highest
Price Target
2.1 USD
396% Upside
Biodesix Inc Competitors:
Price Targets
EUDA
EUDA Health Holdings Ltd
152% Upside
HI
Health Italia SpA
33% Upside
ASTH
Apollo Medical Holdings Inc
49% Upside
V3V
Vita 34 AG
8% Upside
EUDA
EUDA Health Holdings Ltd
152% Upside
HI
Health Italia SpA
33% Upside
ASTH
Apollo Medical Holdings Inc
49% Upside
V3V
Vita 34 AG
8% Upside
T
TALK
Talkspace Inc
74% Upside
KRSNAA
Krsnaa Diagnostics Ltd
43% Upside
IDHC
Integrated Diagnostics Holdings PLC
116% Upside
LFST
Lifestance Health Group Inc
55% Upside

Revenue
Forecast

Revenue Estimate
Biodesix Inc

For the last 5 years the compound annual growth rate for Biodesix Inc's revenue is 24%. The projected CAGR for the next 3 years is 22%.

24%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Biodesix Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Biodesix Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-70%
Average Miss
What are analyst estimates?

See Also

Summary
BDSX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BDSX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BDSX stock valuation using valuation multiples.
Wall Street Estimates
BDSX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BDSX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BDSX's stock price target?
Price Target
1.785 USD

According to Wall Street analysts, the average 1-year price target for BDSX is 1.785 USD with a low forecast of 1.515 USD and a high forecast of 2.1 USD.

What is Biodesix Inc's Revenue forecast?
Projected CAGR
22%

For the last 5 years the compound annual growth rate for Biodesix Inc's revenue is 24%. The projected CAGR for the next 3 years is 22%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 277,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.